News Search

Tag: By PCI

Carisma Therapeutics continues to thrive and expand

Penn and Carisma Therapeutics (Carisma) have strengthened the intellectual property portfolio covering this technology with the issuance of five additional patents in 2022.

Staff Spotlight: Meet PCI’s Newest Team Members

Meet PCI's newest staff members and read their bios.

Penn ICorps Graduate and President’s Innovation Prize Winner Strella Biotech Raises $8 Million in Series A Funding Round

Read about how this Philadelphia-based agricultural biotech startup received funding from Mark Cuban, Google Ventures, and others.

Penn Spinout Regenxbio Opens New Gene Therapy Manufacturing Facility in Maryland

Regenxbio, a gene therapy company founded through collaboration with PCI, opened a new facility at its Maryland campus.

Abrax Japan licenses technology from Penn

Abrax Japan entered into an exclusive licensing agreement for certain Penn-owned inventions relating to the therapeutic effects of thymic stromal lymphopoietin (TSLP).

IBA partners with Penn Medicine to develop flash therapy

IBA Worldwide, a technology company that develops particle accelerator technology, partnered with a team of faculty from Radiation Oncology at Penn Medicine led by Dr. James Metz.

JPOD @ Philadelphia: Webinar Recording

Olivia McPherson, Program Manager, JPOD@PHILADELPHIA, shares how the JPOD and Johnson & Johnson's JLABS program helps startups with life science commercialization.

Webinar Recording: IP Trends for Emerging Penn Engineering Technologies

This webinar discusses the latest trends in intellectual property and patenting for engineers, including robotics, nanotechnology, med-tech and more

Penn Startups Raising Capital – Spring 2022

PCI supports and facilitates startup formation and growth through our startup creation programs and our licensing partnerships. This list of Penn affiliated startups are actively fundraising.

USPTO launches new Patent Public Search tool and webpage

The USPTO announced a new Patent Public Search tool that provides more convenient, remote, and robust full-text searching of all U.S. patents and published patent applications.


Skip to content